Reduction of 5-fluorouracil toxicity in man with retention of anticancer effects by prolonged intravenous administration in 5 per cent dextrose.
D061605:Administration, Intravenous; D064420:Drug-Related Side Effects and Adverse Reactions; D005472:Fluorouracil; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D014498:Uracil / Q000031:analogs & derivatives
D014498:Uracil; D005947:Glucose; D005472:Fluorouracil
GLUCOSE/pharmacology; NEOPLASMS/therapy; URACIL/related compounds